Scientific Papers

Pignataro, M.F., et al. TB vaccine development: monitoring international patent filings to anticipate access challenges. Front Public Health, 2026 Jan 16, 13:1726153. PMID: 41626371   This [...]

Quan, Y., et al. Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice. Viruses, 2025 Dec 30, 18(1):53. PMID: 41600818   This study addresses the significant public health [...]

Respiratory syncytial virus (RSV) is a leading cause of respiratory illness across all age groups, particularly affecting infants, older adults, and individuals with chronic health conditions, [...]

Herpes zoster (shingles) and its complication, herpes zoster ophthalmicus (HZO), are associated with an increased risk of cardiovascular events such as heart attacks and strokes, especially in [...]

The development of an effective HIV-1 vaccine remains a global health priority due to the persistent high prevalence of HIV/AIDS despite advances in treatment and prevention strategies. While [...]

This paper provides an overview of QS-21, a potent saponin-based adjuvant derived from the bark of Quillaja saponaria, highlighting its significant role in enhancing both humoral and cellular [...]

Yue, S., et al. Purification of Quillaja saponins QS-21Xyl and QS-21Api by hydrophilic interaction chromatography. Carbohydr Res, 2025 Nov 8, 559:109741. PMID: 41223814 The primary goal of this [...]

Wagner, A.A., et al. Accessing robust vaccine coformulation stability by single adjuvant detection on a microelectrode. Proc Natl Acad Sci U S A, 2025 Nov 4, 122(44):e2522044122. PMID: 41150712 [...]

Komla, E., et al. Red blood cells as probes for determining free QS21 in liposomal adjuvant formulations to support product safety and stability. Anal Methods, 2025 Nov 20, 17(45):9162-9170.  [...]

Uzar, S., et al. Formulation of inactivated and adjuvanted combined bovine rotavirus and bovine coronavirus candidate vaccine and immunity studies in mice. Vaccine, 2025 Nov 20, 67:127901, [...]